Beth Hill is Platform Leader at J&J Innovation, working to create partnerships that accelerate the creation of transformational medicines. Beth is an experienced pharmaceutical innovator with >20 years of strategic and operational leadership. Formerly with Janssen R&D, Beth led global cross-disciplinary functions working from late discovery through development and commercialization. Previously, at Corixa, Beth led R&D teams to develop biologics for cancer and autoimmune disease. At Systemix /Novartis she held leadership roles in stem cell, somatic cell and gene therapy discovery and development. Beth began her industrial career developing diagnostics at Syva Co. Beth earned her BA in Medical Technology at Augustana College (Rock Island, IL), her PhD in Microbiology at Columbia University (NYC), and post-doc’d at Stanford in the Dept of Structural Biology.